Pfizer Inc (NYSE: PFE) reported a loss for the third quarter on Tuesday.
Pfizer reported a quarterly adjusted EPS loss of 17 cents versus a consensus loss of 32 cents, down from an EPS income of 67 cents in Q2 and $1.78 a year ago. The company reported a 42% slump in Q3 sales to $13.23 billion, down from $22.64 billion a year ago, beating the consensus of $12.72 billion.
With the buzz around Pfizer following quarterly earnings, some investors may be eyeing potential gains from the company’s dividends. As of now, Pfizer offers an annual dividend yield of 5.37%, which is a quarterly dividend amount of 41 cents per share ($1.64 a year).
So, how can investors exploit ...